4
Changes in Ownership
Arcus Biosciences, Inc. Filed Acc 0001734422-26-000005
Director acquired 5,700 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lacey David L. Director | 2026-06-11 | Grant or award | +5,700 | 76,652 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lacey David L. Director | 2026-06-11 | Grant or award · Stock Option (Right to Buy) | +16,900 | 16,900 | D: show line 2 in the form |
Loading xslF345X06/wk-form4_1781296084.xml…